Bristol-Myers Squibb Rights
CELG.RT
23 hedge funds and large institutions have $200K invested in Bristol-Myers Squibb Rights in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
22% more capital invested
Capital invested by funds: $164K → $200K (+$35.9K)
10% more funds holding
Funds holding: 21 → 23 (+2)
0% more ownership
Funds ownership: 0.03% → 0.03% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$3.6K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.14K |
| 3 |
OC
Oakworth Capital
Birmingham,
Alabama
|
+$20 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$14K |
| 2 |
DC
Davenport & Co
Richmond,
Virginia
|
-$158 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FCM
1
FourWorld Capital Management
New York
| $69K | +$16.3K | +100,000 | New |
|
|
MS
2
Maven Securities
St Helier,
Jersey
| $47K | – | – | – |
|
|
3
Citadel Advisors
Miami,
Florida
| $19K | -$14K | -86,129 | -41% |
|
|
TCA
4
Transcend Capital Advisors
Madison,
New Jersey
| $18K | – | – | – |
|
|
DC
5
Davenport & Co
Richmond,
Virginia
| $14K | -$158 | -967 | -1% |
|
|
5L
6
55I LLC
Boston,
Massachusetts
| $13K | – | – | – |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $7K | +$2.14K | +13,141 | +36% |
|
8
Fifth Third Bancorp
Cincinnati,
Ohio
| $3K | – | – | – |
|
|
PWP
9
Private Wealth Partners
Mill Valley,
California
| $3K | – | – | – |
|
|
10
UBS Group
Zurich,
Switzerland
| $3K | +$3.6K | +22,083 | +122,683% |
|
|
PAG
11
Private Advisor Group
Morristown,
New Jersey
| $2K | – | – | – |
|
|
TPA
12
Trivium Point Advisory
Westport,
Connecticut
| $2K | – | – | – |
|
13
Koshinski Asset Management
Decatur,
Illinois
| $300 | – | – | – |
|
|
14
Bank of America
Charlotte,
North Carolina
| – | +$5 | +30 | +2% |
|
|
OC
15
Oakworth Capital
Birmingham,
Alabama
| – | +$20 | +125 | New |
|
CELG.RT Hedge Fund Activity: Q1 2022 in Review
23 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q1 2022, worth a combined $200K — up 22% from $164K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CELG.RT positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, adding an estimated $3.6K. The largest seller was Citadel Advisors, cutting an estimated $14K.
- 23 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q1 2022, up from 21 in Q4 2021.
- Funds reported $200K of Bristol-Myers Squibb Rights stock for Q1 2022, up 22% quarter-over-quarter.
- 2 funds opened new Bristol-Myers Squibb Rights positions in Q1 2022 and 0 closed out, a net change of +2 holders.
- The largest Bristol-Myers Squibb Rights buyer in Q1 2022 was UBS Group, an estimated $3.6K added.
- The largest Bristol-Myers Squibb Rights seller in Q1 2022 was Citadel Advisors, an estimated $14K sold.
Based on aggregated 13F filings for Q1 2022.